BMX and prostate carcinoma: Inhibition of BTK and ETK with a small molecule inhibitor caused inhibition of proliferation, clonogenic growth, invasiveness of human prostate cancer cell lines both in in vitro and an in vivo SCID mouse xenograft model (Guo et al., 2014).